Coronary revascularization of patients with silent coronary ischemia may reduce the risk of myocardial infarction and cardiovascular death after carotid endarterectomy

Krieviņš, Dainis; Zellāns, Edgars; Latkovskis, Gustavs; Babuškina, Inna; Kumsārs, Indulis; Jēgere, Sanda; Zvaigzne, Ligita; Krievina, Agate K.; Ērglis, Andrejs; Zarins, Christopher K.

doi:10.1016/j.jvs.2022.05.004

Cited by 10 publications

(4 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Section: Preoperative Risk Assessmentmentioning

confidence: 99%

“…undertook a series of studies including patients without cardiac history or symptoms who were due to undergo elective vascular surgery. [33][34][35] All patients underwent preoperative CT-FFR , which identified silent ischaemia (CT-FFR<0.80) in 57-68% of patients, and severe ischaemia (CT-FFR<0.75) in 43-53%. [33][34][35] No patients had preoperative revascularization, however 33-40%…”

Section: Anatomical Assessmentmentioning

confidence: 99%

“…[33][34][35] All patients underwent preoperative CT-FFR , which identified silent ischaemia (CT-FFR<0.80) in 57-68% of patients, and severe ischaemia (CT-FFR<0.75) in 43-53%. [33][34][35] No patients had preoperative revascularization, however 33-40%…”

Section: Anatomical Assessmentmentioning

confidence: 99%

“…In the most recent of this series, the 3-year MACE rate was 4% in those who had undergone revascularization following carotid endarterectomy, compared with 17% in controls, with fewer cardiac deaths (HR: 0.20, 95% CI: 0.04-0.95) and MI (HR: 0.16, 95% CI: 0.05-0.54) also observed. 34 The 2022 ESC guidelines recommend functional testing in patients undergoing high-risk elective surgery who have poor functional capacity, multiple risk factors or previous revascularization, or intermediate risk "when ischaemia is of concern". 3 When selecting preferred modality, local availability may dictate choice.…”

Section: Anatomical Assessmentmentioning

confidence: 99%

See 3 more Smart Citations

Assessment and Management of Ischaemic Heart Disease in Non-Cardiac Surgery

Morgan,

Ezad,

Rahman

et al. 2023

Heart International

View full text Add to dashboard Cite

In the setting of non-cardiac surgery, cardiac complications contribute to over a third of perioperative deaths. With over 230 million major surgeries performed annually, and an increasing prevalence of cardiovascular risk factors and ischaemic heart disease, the incidence of perioperative myocardial infarction is also rising. The recent European Society of Cardiology guidelines on cardiovascular risk in non-cardiac surgery elevated practices aiming to identify those at most risk, including biomarker monitoring and stress testing. However the current evidence base on if, and how, the risk of cardiac events can be modified is lacking. This review focuses on patient, surgical and cardiac risk assessment, as well as exploring the data on perioperative revascularization and other risk-reduction strategies.

show abstract

Section: Preoperative Risk Assessmentmentioning

confidence: 99%